InvestorsHub Logo
Followers 4
Posts 335
Boards Moderated 0
Alias Born 01/16/2001

Re: None

Sunday, 07/31/2022 10:17:26 AM

Sunday, July 31, 2022 10:17:26 AM

Post# of 457788
“Previously, this study demonstrated dose-dependent, statistically significant improvement of dementia assessment, Quality of Episodic Memory with ANAVEX®2-73 (p=0.003) as well as significant improvement of Parkinson’s assessment, MDS-UPDRS Total score (p=0.034), in patients treated with ANAVEX®2-73 high oral dose once daily during the 14-week trial.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News